ZA200204859B - Method of decreasing fasting sugars and weight gains in diabetic patients. - Google Patents

Method of decreasing fasting sugars and weight gains in diabetic patients.

Info

Publication number
ZA200204859B
ZA200204859B ZA200204859A ZA200204859A ZA200204859B ZA 200204859 B ZA200204859 B ZA 200204859B ZA 200204859 A ZA200204859 A ZA 200204859A ZA 200204859 A ZA200204859 A ZA 200204859A ZA 200204859 B ZA200204859 B ZA 200204859B
Authority
ZA
South Africa
Prior art keywords
diabetic patients
weight gains
decreasing fasting
sugars
fasting sugars
Prior art date
Application number
ZA200204859A
Other languages
English (en)
Inventor
Landschulz William Harras
Original Assignee
Pfitzer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfitzer Products Inc filed Critical Pfitzer Products Inc
Publication of ZA200204859B publication Critical patent/ZA200204859B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Otolaryngology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
ZA200204859A 2001-06-21 2002-06-18 Method of decreasing fasting sugars and weight gains in diabetic patients. ZA200204859B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30004901P 2001-06-21 2001-06-21

Publications (1)

Publication Number Publication Date
ZA200204859B true ZA200204859B (en) 2004-01-28

Family

ID=23157477

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200204859A ZA200204859B (en) 2001-06-21 2002-06-18 Method of decreasing fasting sugars and weight gains in diabetic patients.

Country Status (15)

Country Link
US (2) US20030079747A1 (de)
EP (1) EP1270012A1 (de)
JP (1) JP2003012543A (de)
KR (1) KR20020097033A (de)
CN (1) CN1289143C (de)
AU (1) AU4884102A (de)
CA (1) CA2390757A1 (de)
CZ (1) CZ20022151A3 (de)
HK (1) HK1049617B (de)
HU (1) HUP0202042A3 (de)
IL (1) IL150209A0 (de)
NZ (1) NZ519403A (de)
PL (1) PL354641A1 (de)
SK (1) SK9042002A3 (de)
ZA (1) ZA200204859B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004054606A1 (en) * 2002-12-13 2004-07-01 Pfizer Products Inc. Method of decreasing hepatic glucose output in diabetic patients
WO2004078196A1 (en) * 2003-03-04 2004-09-16 The Technology Development Company Ltd. Oral insulin composition and methods of making and using thereof
JP2009519972A (ja) * 2005-12-15 2009-05-21 アキュスフィア， インコーポレイテッド 粒子ベースの経肺投与または経鼻投与用製薬の製造方法
WO2008118387A2 (en) * 2007-03-23 2008-10-02 Wayne State University Erythrocyte atp-release modulators
EP2060268A1 (de) * 2007-11-15 2009-05-20 Novo Nordisk A/S Pharmazeutische Zusammensetzungen für die Zufuhr von Peptiden über die Lunge oder Nase
JP5650734B2 (ja) * 2009-07-22 2015-01-07 イーライ リリー アンド カンパニー 薬物療法に関連する体重増加を予測するための方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5230884A (en) * 1990-09-11 1993-07-27 University Of Wales College Of Cardiff Aerosol formulations including proteins and peptides solubilized in reverse micelles and process for making the aerosol formulations
DK10191D0 (da) * 1991-01-22 1991-01-22 Novo Nordisk As Hidtil ukendte peptider
DE69233690T2 (de) * 1991-07-02 2008-01-24 Nektar Therapeutics, San Carlos Abgabevorrichtung für nebelförmige Medikamente
US5320094A (en) * 1992-01-10 1994-06-14 The Johns Hopkins University Method of administering insulin
US5785049A (en) * 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
US6582728B1 (en) * 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
US6024090A (en) * 1993-01-29 2000-02-15 Aradigm Corporation Method of treating a diabetic patient by aerosolized administration of insulin lispro
US5743250A (en) * 1993-01-29 1998-04-28 Aradigm Corporation Insulin delivery enhanced by coached breathing
US6051256A (en) * 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
KR100419037B1 (ko) * 1994-03-07 2004-06-12 넥타르 테라퓨틱스 폐를통한인슐린의전달방법및그조성물
CN1131080C (zh) * 1994-09-21 2003-12-17 吸入治疗系统 用于喷洒干的粉末药物的方法和装置
US5898028A (en) * 1997-03-20 1999-04-27 Novo Nordisk A/S Method for producing powder formulation comprising an insulin
DE19733651A1 (de) * 1997-08-04 1999-02-18 Boehringer Ingelheim Pharma Wässrige Aerosolzubereitungen enthaltend biologisch aktive Markomoleküle und Verfahren zur Erzeugung entsprechender Aerosole
DE69920767T2 (de) * 1998-10-16 2006-02-02 Novo Nordisk A/S Stabile konzentrierte Insulin Präparationen zur pulmonaren Verabreichung
EP1173482A1 (de) * 1999-04-27 2002-01-23 Eli Lilly And Company Insulinkristalle zur aufnahme über die lunge
AU5453300A (en) * 1999-06-29 2001-01-31 Eli Lilly And Company Insulin crystals for pulmonary administration
US7060675B2 (en) * 2001-02-15 2006-06-13 Nobex Corporation Methods of treating diabetes mellitus
US6838442B2 (en) * 2001-04-04 2005-01-04 Ortho-Mcneil Pharmaceutical, Inc. Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators
AU2002303869B2 (en) * 2001-05-21 2007-08-16 Novartis Ag Pulmonary administration of chemically modified insulin

Also Published As

Publication number Publication date
EP1270012A1 (de) 2003-01-02
HUP0202042A3 (en) 2004-06-28
AU4884102A (en) 2003-01-02
PL354641A1 (en) 2002-12-30
CN1289143C (zh) 2006-12-13
CN1393265A (zh) 2003-01-29
CZ20022151A3 (cs) 2003-04-16
KR20020097033A (ko) 2002-12-31
NZ519403A (en) 2005-03-24
HU0202042D0 (de) 2002-08-28
US20050220722A1 (en) 2005-10-06
CA2390757A1 (en) 2002-12-21
HK1049617B (zh) 2007-03-16
US20030079747A1 (en) 2003-05-01
JP2003012543A (ja) 2003-01-15
SK9042002A3 (en) 2003-05-02
HK1049617A1 (en) 2003-05-23
HUP0202042A2 (hu) 2004-05-28
IL150209A0 (en) 2002-12-01

Similar Documents

Publication Publication Date Title
GB2385280B (en) Gaming system and gaming method
AU2003230813A1 (en) Online league and tournament system
AU2003248675A1 (en) Gaming system and method
IL164400A0 (en) Deruvatuves if n-Äphenyl(piperidin-2-yl)methylÜbenzamide, the preparation method thereof and application of same in therapeutics
AU2003245026A1 (en) Multipurpose processor, system and method
EP1427401A4 (de) Verfahren zur verringerung von hypertonie und herzinsuffizienz
AU2002310076A1 (en) Structure and method to preserve sti during etching
AU2001276952A1 (en) Method of treating the syndrome of coronary heart disease risk factors in humans
AU2001282550A1 (en) Method of quantifying total hemoglobin and glycohemoglobin
GB0110288D0 (en) Composition and treatment method
AU2003214775A1 (en) Physiologically compatible cardiac assist device and method
PL354191A1 (en) Laminated material, application thereof and method of obtaining same
AU2003214725A1 (en) Preventing and/or treating cardiovascular disease and/or associated heart failure
AU2002349237A1 (en) Coring system and method
AU2002367023A1 (en) Compositions and methods for treating heart failure
AU2002351206A1 (en) Lateral lubistor structure and method
AU2002320056A1 (en) Apparatus and method for reducing heart pump backflow
AU2002365057A1 (en) Compositions and methods for treating heart failure
ZA200204859B (en) Method of decreasing fasting sugars and weight gains in diabetic patients.
AU2003224956A1 (en) Reference structures and reference structure enhanced tomography
AU2002366813A1 (en) Cardiac pacing method and system
AU2002316162A1 (en) Method of increasing anti-neugc antibody levels in blood
AU1907901A (en) Sandwich construction and method for its manufacture
EP1187337A4 (de) Sprachkodierer,sprachprozessor und sprachverarbeitungsmethode
AU2003278754A1 (en) Motocycle lift bar and method